{"id":"https://openalex.org/W4234780109","doi":"https://doi.org/10.1016/0376-8716(85)90066-3","title":"Nalbuphine","display_name":"Nalbuphine","alternate_titles":[],"publication_year":1985,"publication_date":"1985-02-01","ids":{"openalex":"https://openalex.org/W4234780109","doi":"https://doi.org/10.1016/0376-8716(85)90066-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/2986929"},"language":"en","primary_location":{"id":"doi:10.1016/0376-8716(85)90066-3","doi":"https://doi.org/10.1016/0376-8716(85)90066-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0376-8716(85)90066-3","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4234780109"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032472337","display_name":"William K Schmidt","orcid":"https://orcid.org/0000-0001-5841-4810","observed_orcids":["https://orcid.org/0000-0001-5841-4810"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"William K. Schmidt","raw_affiliation_strings":["Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077001178","display_name":"S. William Tam","orcid":"https://orcid.org/0009-0003-5362-2022","observed_orcids":["https://orcid.org/0009-0003-5362-2022"]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S.William Tam","raw_affiliation_strings":["Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037442879","display_name":"Gregory S. Shotzberger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gregory S. Shotzberger","raw_affiliation_strings":["Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075598838","display_name":"Dewey H. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dewey H. Smith","raw_affiliation_strings":["Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Clark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Clark","raw_affiliation_strings":["Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A","institution_ids":["https://openalex.org/I1316910977"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064567303","display_name":"Vernon G. Vernier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316910977","display_name":"DuPont (United States)","ror":"https://ror.org/03g3m1w62","country_code":"US","type":"company","lineage":["https://openalex.org/I1316910977"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vernon G. Vernier","raw_affiliation_strings":["Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceuticals Research & Development Division, Du Pont Pharmaceuticals, E.I. du Pont de Nemours & Co., Inc., Wilmington, DE 19898 U.S.A","institution_ids":["https://openalex.org/I1316910977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032472337"],"corresponding_institution_ids":["https://openalex.org/I1316910977"],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":null,"fwci":0.9615,"has_fulltext":false,"cited_by_count":232,"citation_normalized_percentile":{"value":0.78571429,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"14","issue":"3-4","first_page":"339","last_page":"362"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.9312000274658203,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.03550000116229057,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10189","display_name":"Anesthesia and Pain Management","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nalbuphine","display_name":"nalbuphine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.6499999761581421},{"id":"https://openalex.org/keywords/mu-opioid-receptor-antagonist","display_name":"mu-opioid receptor antagonist","score":0.9509999752044678},{"id":"https://openalex.org/keywords/opioid-analgesics","display_name":"opioid analgesics","score":0.8389999866485596},{"id":"https://openalex.org/keywords/opioid-receptor-antagonism","display_name":"opioid antagonism","score":0.5080000162124634},{"id":"https://openalex.org/keywords/respiratory-depression","display_name":"respiratory depression","score":0.6859999895095825},{"id":"https://openalex.org/keywords/naloxone-reversal","display_name":"naloxone reversal","score":0.671999990940094},{"id":"https://openalex.org/keywords/morphine-withdrawal","display_name":"morphine withdrawal","score":0.6800000071525574},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.7139999866485596},{"id":"https://openalex.org/keywords/abuse-potential","display_name":"abuse liability","score":0.7390000224113464},{"id":"https://openalex.org/keywords/psychotomimetic-effects","display_name":"psychotomimetic effects","score":0.7860000133514404},{"id":"https://openalex.org/keywords/gastrointestinal-motility","display_name":"gastrointestinal motility","score":0.7620000243186951},{"id":"https://openalex.org/keywords/opioid-tolerance","display_name":"opioid tolerance","score":0.3240000009536743},{"id":"https://openalex.org/keywords/pentazocine","display_name":"pentazocine","score":0.7940000295639038},{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9330000281333923},{"id":"https://openalex.org/keywords/nalorphine","display_name":"nalorphine","score":0.9300000071525574}],"concepts":[{"id":"https://openalex.org/C2778977083","wikidata":"https://www.wikidata.org/wiki/Q277979","display_name":"Nalbuphine","level":4,"score":0.9971481561660767},{"id":"https://openalex.org/C2776657501","wikidata":"https://www.wikidata.org/wiki/Q2622916","display_name":"Nalorphine","level":5,"score":0.9544070959091187},{"id":"https://openalex.org/C2780802079","wikidata":"https://www.wikidata.org/wiki/Q415793","display_name":"Pentazocine","level":3,"score":0.9170470237731934},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.672553539276123},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.6241892576217651},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.5143634080886841},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5005366802215576},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4831773340702057},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.46484583616256714},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.441017210483551},{"id":"https://openalex.org/C2778539182","wikidata":"https://www.wikidata.org/wiki/Q4693408","display_name":"Agonist-antagonist","level":4,"score":0.4386093020439148},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40780892968177795},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.39655211567878723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.143090158700943},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06744429469108582}],"mesh":[{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000882","descriptor_name":"Haplorhini","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003864","descriptor_name":"Depression, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004192","descriptor_name":"Discrimination, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009019","descriptor_name":"Morphinans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009266","descriptor_name":"Nalbuphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009266","descriptor_name":"Nalbuphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009266","descriptor_name":"Nalbuphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012119","descriptor_name":"Respiration","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012646","descriptor_name":"Self Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012894","descriptor_name":"Sleep Stages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017473","descriptor_name":"Receptors, Opioid, kappa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0376-8716(85)90066-3","doi":"https://doi.org/10.1016/0376-8716(85)90066-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0376-8716(85)90066-3","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},{"id":"pmid:2986929","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2986929","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and alcohol dependence","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W399154554","https://openalex.org/W1900414416","https://openalex.org/W1910195644","https://openalex.org/W1979116564","https://openalex.org/W1980054112","https://openalex.org/W1993888521","https://openalex.org/W2006339919","https://openalex.org/W2011990892","https://openalex.org/W2012435499","https://openalex.org/W2014856462","https://openalex.org/W2017952011","https://openalex.org/W2024978043","https://openalex.org/W2028264797","https://openalex.org/W2030659757","https://openalex.org/W2056272282","https://openalex.org/W2063136461","https://openalex.org/W2065957212","https://openalex.org/W2071087516","https://openalex.org/W2075756452","https://openalex.org/W2075811628","https://openalex.org/W2078237064","https://openalex.org/W2089479693","https://openalex.org/W2098957364","https://openalex.org/W2110378146","https://openalex.org/W2119109276","https://openalex.org/W2249543568","https://openalex.org/W2253032570","https://openalex.org/W2284291032","https://openalex.org/W2345247159","https://openalex.org/W2405473372","https://openalex.org/W2425341829","https://openalex.org/W4289959101"],"related_works":["https://openalex.org/W2011534717","https://openalex.org/W2417532180","https://openalex.org/W2345247159","https://openalex.org/W7219432151","https://openalex.org/W1903738413","https://openalex.org/W1903137571","https://openalex.org/W2098957364","https://openalex.org/W2077232090","https://openalex.org/W7217127906"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4234780109","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2022-05-12T00:00:00"}
